Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardioSounds is a medical technology company based in Ann Arbor, Michigan, that develops non-invasive solutions for continuous cardiovascular monitoring. Founded in 2018, the company commercializes vibro-acoustic technology developed at Wayne State University and the University of Michigan to capture cardiac vibrational and electrical signals. Their primary product is a wearable sensor system that utilizes proprietary AI algorithms to provide continuous, real-time monitoring of blood pressure and hemodynamic state without the need for invasive arterial lines or intermittent cuffs. The technology is currently being evaluated for diverse clinical applications, including the management of heart failure, monitoring COVID-19 disease progression, and providing early warning of hemodynamic collapse in critical care settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CardioSounds.